Orlistat
Lipase-inhibiting pellets created for weight management therapies, formulated to minimise oily spotting and maintain potency.
Product overview
Orlistat pellets deliver lipase inhibition for obesity management programs that require reliable gastrointestinal targeting. Rraynex prepares pellets using solvent layering and controlled drying, ensuring the active remains evenly distributed and within potency limits. Protective coatings minimize oily spotting and help the active survive capsule filling, stick packs, or sachet presentations. Particle size control delivers smooth flow through high-speed equipment while maintaining low dust levels for operator safety. Documentation packages provide dissolution behavior in simulated intestinal fluid, impurity trends, and stability data across temperate and tropical climates. We offer packaging options from moisture-resistant drums to small nitrogen-flushed bags for pilot launches. Technical partners receive support on capsule fill optimization, flavor masking, and excipient compatibility, including blends with cellulose, mannitol, or silicon dioxide. With strong change-control governance and rapid quality responses, Rraynex keeps orlistat supply dependable as brands expand weight-management portfolios.
Technical specifications
- Grade
- IP / BP / USP / EP
- Type
- Pellets
- Category
- Anti-Obesity
- Pack size
- 25/50 kg
- Available strengths
- 50%
- Certifications
- WHO-GMP, ISO 9001, ISO 14001
